
專業(yè)職稱:研究員
院內職務:藥物I期臨床試驗研究室副主任(主持工作)兼藥物及醫(yī)療器械臨床試驗機構辦公室主任(中層副職)
個人簡介:
[科室]藥物Ⅰ期臨床試驗研究室
[職稱] 研究員
[職務] 藥物I期臨床試驗研究室副主任(主持工作)兼藥物及醫(yī)療器械臨床試驗機構辦公室主任(中層副職)
[學位] 博士研究生
教育背景
2013-09至2018-06,首都醫(yī)科大學,免疫學,博士
2002-09至2005-06,河北醫(yī)科大學,藥物分析,碩士
1998-09至2002-06,河北醫(yī)科大學,藥學,本科
工作經歷
2022年9月-至今 北京世紀壇醫(yī)院藥物I期研究室副主任
2016年5月-2022年8月 北京地壇醫(yī)院I期臨床試驗病房負責人
2013年5月-2022年8月 北京地壇醫(yī)院藥物臨床試驗機構辦公室主任
2006年9月-2013年4月 北京地壇醫(yī)院研究所
2005年7月-2006年8月 北京地壇醫(yī)院藥劑科
聯(lián)系方式
聯(lián)系電話:010-63926402
2022 北京市科學技術進步獎二等獎
1. Dong Zhao, Jun Ni, Wen Zhang, Yibo Zhou, Di Chang, Zhenhua Yang, Yansong Wang, Xiangmei Zhao, Xiaohua Hao*. Pharmacokinetics, Bioequivalence, and Safety Evaluation of Dienogest in Healthy Subjects Under Fasting and Fed Conditions. Clin Pharmacol Drug Dev. 2023 Apr;12(4):350-355.
2.Yunlong Cao , Xiaohua Hao #(共同第一作者), Xi Wang , Qianhui Wu , Rui Song, Dong Zhao, Weiliang Song, Yao Wang, Ayijiang Yisimayi, Wei Wang, Wen Zhang, Juan Du, Hongjie Yu, Xiaoliang Sunney Xie, Ronghua Jin. Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine. Cell Res. 2022 Jan;32(1):107-109.
3.Xiaohua Hao , Zheng Zhang, Ji Ma , Lin Cheng , Yun Ji , Yang Liu , Dong Zhao , Wen Zhang , Chunming Li , Li Yan , David Margolis , Qing Zhu , Yao Zhang , Fujie Zhang. Randomized, placebo-controlled, single-blind phase 1 studies of the safety, tolerability, and pharmacokinetics of BRII-196 and BRII-198, SARS-CoV-2 spike-targeting monoclonal antibodies with an extended half-life in healthy adults. Front Pharmacol. 2022 Sep 6;13:983505.
4.Xiaohua Hao, Meixin Gao, Lingling He, Xiaohui Ye, Junru Yang, Fuyang Zhang, Ran Liu, Hongshan Wei. Deficiency of O-linked-glycosylation regulates activation of T cells and aggravates Concanavalin A-induced liver injury. Toxicology, 2020, 433–434, 152411.
5.Xiaohua Hao, Yufeng Li, Jianwen Wang, Jiali Ma, Shuli Zhao, Xiaohui Ye, Lingling He, Junru Yang, Meixin Gao, Fan Xiao and Hongshan Wei*. Deficient O-GlcNAc Glycosylation Impairs Regulatory T Cell Differentiation and Notch Signaling in Autoimmune Hepatitis (DOI: 10.3389/fimmu.2018.02089). Frontiers in Immunology, 2018, 9.
6.Hongshan Wei, Xiaohua Hao#(共同第一作者), Boan Li, Xingwang Li, Jun Hou, Yong Qiao, Renwen Zhang, Xin Li. GP73 is a potential marker for evaluating AIDS progression and antiretroviral therapy efficacy. Molecular Biology Reports. 2013, 40(11): 6397-6405.
7.Xiaohua Hao; Ran Liu; Yifan Zhang; Yufeng Li; Qun He; Yubo Huang; Yu Jiang; Jiali Ma; Ping Li; Hongshan Wei*. Glt25d2 Knockout Directly Increases CD25+CD69- but Decreases CD25-CD69+ Subset Proliferation and is Involved in Concanavalin-Induced Hepatitis. Cell Physiol Biochem. 2018, 50(3): 1186-1200.